BMA Q4 2025 Earnings Strong EPS Beat Amidst Mixed Market Reaction PRE Q4 2025 Earnings EPS Falls Sharply Short of Expectations Amid Transition CSL Q1 2026 Earnings EPS Surpasses Estimates by 78 Stock Rises Modestly BXP Q1 2026 Earnings Stellar EPS Beat Highlights Operational Strength Kazia Therapeutics Q1 2026 Earnings A WiderThanExpected Loss Yet Shares Gain Ground AVAH Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines